Skip to contentB
Boston Scientific Corp
B
BSXBoston Scientific Corp Source filing unavailable
Q1 2017 · —
Revenue$2.20B$2.20B+10.2% vs Q1 2016 Net Income$290.00M$290.00M+43.6% vs Q1 2016 EPS Diluted$0.21$0.21+40.0% vs Q1 2016 Gross Profit$1,510,000,000+8.6% Operating Income$364,000,000+24.2% Operating Cash Flow-$7,000,000
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Boston Scientific Corp · CIK 885725 · Engraved from SEC EDGAR
N/M
Free Cash Flowderived-$119,000,000N/M Margins · derivedGross margin68.6%−1.0 pt vs Q1 2016
Operating margin16.5%+1.9 pt vs Q1 2016
Net margin13.2%+3.1 pt vs Q1 2016